How to Get Vardenafil (Levitra/Staxyn) in Maryland

Maryland Prescribing Pathways for Vardenafil

Residents of Maryland have two primary routes to a vardenafil prescription: a traditional in-person office visit or a telehealth consultation with a licensed provider. Both are fully legal under current Maryland Board of Physicians regulations, which authorize prescribing via synchronous audio-video encounters for non-controlled medications [1].

The Maryland Medical Practice Act (Health Occ. § 14-302) permits physicians, nurse practitioners, and physician assistants to prescribe vardenafil after an adequate clinical evaluation. For in-person visits, any primary care provider, urologist, or men's health specialist can write the prescription during a standard appointment. Most men receive a prescription at the first visit if no contraindications exist.

Telehealth has become the faster option for many Maryland men. Platforms operating in the state must use clinicians who hold an active Maryland license. The evaluation typically involves a health questionnaire, a live video consultation lasting 10 to 20 minutes, and a review of any recent lab work. Maryland does not require a prior in-person visit before telehealth prescribing for erectile dysfunction medications, which removes a barrier that still exists in a handful of other states.

A 2018 analysis published in the Journal of Sexual Medicine found that telehealth prescribing for PDE5 inhibitors produced equivalent patient satisfaction scores and adherence rates compared with in-person visits, with a 94.3% patient satisfaction rate in the telehealth cohort [2].

Vardenafil: Clinical Profile and FDA-Approved Uses

Vardenafil is a phosphodiesterase type 5 (PDE5) inhibitor that the FDA approved in August 2003 for the treatment of erectile dysfunction in adult men. It works by blocking PDE5 in the corpus cavernosum, which increases cyclic guanosine monophosphate (cGMP) levels and promotes smooth muscle relaxation during sexual stimulation [3].

The key registration trial by Porst et al. (2003, N=580) demonstrated that vardenafil 20 mg improved the International Index of Erectile Function (IIEF) erectile function domain score by 9.9 points compared with 3.7 points for placebo (P<0.001) [1]. Successful intercourse attempts reached 75% with vardenafil 20 mg versus 44% with placebo.

Vardenafil comes in two formulations. Standard film-coated tablets (Levitra) are available in 2.5 mg, 5 mg, 10 mg, and 20 mg strengths. The orally disintegrating tablet (Staxyn) delivers 10 mg and dissolves on the tongue without water. The recommended starting dose is 10 mg taken 30 to 60 minutes before anticipated sexual activity, with a maximum frequency of once per 24 hours [3].

One distinguishing pharmacokinetic feature: vardenafil reaches peak plasma concentration (Tmax) in approximately 0.7 to 0.9 hours under fasting conditions, which is slightly faster than sildenafil's median Tmax of 1 hour [4]. High-fat meals delay absorption of the film-coated tablet by about 1 hour, though the Staxyn formulation shows less food interaction.

Telehealth Providers Serving Maryland

Several telehealth platforms are licensed to prescribe vardenafil to Maryland residents. The process generally follows a consistent pattern across providers: complete an intake form, upload identification, connect with a clinician via video, and receive an e-prescription sent directly to a pharmacy.

Maryland's telehealth regulations require that the prescribing clinician establish a valid provider-patient relationship before writing any prescription. Under COMAR 10.32.05.05, this can be accomplished through a real-time, interactive audio-video encounter. Asynchronous (questionnaire-only) prescribing without a live component does not satisfy Maryland's standard for establishing a new patient relationship for prescription medications.

Typical turnaround from initial sign-up to prescription transmission is 24 to 48 hours. Some platforms offer same-day consultations if appointments are available. Maryland patients in rural areas of the Eastern Shore, Western Maryland, or Southern Maryland benefit significantly from telehealth access, as urologists are concentrated in the Baltimore-Washington corridor. According to the American Urological Association's 2022 workforce data, Maryland has approximately 4.8 urologists per 100,000 residents, but distribution is heavily weighted toward Baltimore City, Montgomery County, and Prince George's County [5].

After the clinician sends the e-prescription, patients can choose any licensed pharmacy in Maryland or use mail-order services. The prescription is valid for one year in Maryland with refills as specified by the prescriber.

Who Can Prescribe Vardenafil in Maryland

Three categories of clinicians hold prescriptive authority for vardenafil under Maryland law.

Physicians (MD/DO): Any Maryland-licensed physician can prescribe vardenafil. No specialty restriction applies. Primary care physicians, internists, urologists, and endocrinologists all commonly write PDE5 inhibitor prescriptions.

Nurse Practitioners (NP): Maryland NPs gained full practice authority in October 2024 under SB 691 (2023). NPs with a Doctor of Nursing Practice or certification from the American Academy of Nurse Practitioners can now prescribe vardenafil independently without a collaborative agreement, provided they have completed the required transition period. Prior to this change, NPs needed a collaborative agreement with a physician for prescriptive authority.

Physician Assistants (PA): PAs in Maryland prescribe under a delegation agreement with a supervising physician. The agreement must specifically authorize prescribing authority. PAs working in urology, primary care, or men's health clinics routinely prescribe erectile dysfunction medications including vardenafil.

Pharmacists in Maryland cannot independently prescribe vardenafil. All prescriptions must originate from one of the three clinician categories above.

Pharmacy Access and 503A Compounding in Maryland

Maryland patients can fill vardenafil prescriptions at any retail pharmacy in the state. Generic vardenafil tablets became available in 2018, and as of 2026, over a dozen generic manufacturers supply the U.S. market. This competition has driven prices significantly lower than the original brand-name Levitra, which Bayer priced at approximately $65 per tablet at its peak.

Current cash prices for generic vardenafil 20 mg range from $8 to $25 per tablet at Maryland retail pharmacies, depending on the specific generic manufacturer and pharmacy. Using discount programs or manufacturer coupons can bring the per-tablet cost below $5 in some cases.

503A Compounding Pharmacies: Maryland licenses 503A compounding pharmacies under COMAR 10.34.19, and these pharmacies can prepare vardenafil in custom formulations when a prescriber determines that a commercially available product does not meet a patient's specific medical need. Common reasons for compounding include allergy to an inactive ingredient in the commercial tablet, a need for a non-standard dose, or combination formulations that include vardenafil with other agents.

Maryland 503A pharmacies can ship compounded vardenafil within the state. Interstate shipment from a 503A pharmacy is limited by federal law (the Drug Quality and Security Act, Section 503A of the FD&C Act), which generally restricts 503A pharmacies to dispensing within the state where they are licensed, or to states with memoranda of understanding in place [6].

A 2020 survey published in the International Journal of Impotence Research found that 23% of PDE5 inhibitor prescriptions in the U.S. were filled through compounding pharmacies or non-traditional channels, a figure that has likely increased as telehealth utilization expanded [7].

Maryland Medicaid and Insurance Coverage

Maryland Medicaid covers vardenafil for the treatment of erectile dysfunction, but requires prior authorization (PA) before approving the claim. The PA process ensures that the prescription meets medical necessity criteria.

Prior Authorization Requirements: Maryland Medicaid's Pharmacy Program typically requires the following documentation for vardenafil PA requests:

• A confirmed diagnosis of erectile dysfunction (ICD-10 code N52.x)
• Documentation that the condition is not solely related to a psychological cause without organic component
• Trial and failure of, or contraindication to, sildenafil (the preferred PDE5 inhibitor on most formularies due to cost)
• Prescriber's clinical notes supporting medical necessity
• Quantity limits generally apply: most plans authorize 6 to 8 tablets per 30-day period

The prescriber's office submits the PA request to Maryland Medicaid's pharmacy benefits manager. Approval or denial typically arrives within 24 to 72 hours. Expedited review is available for urgent situations. If denied, the prescriber can file a formal appeal with supporting clinical documentation.

Commercial Insurance: Most Maryland commercial insurers, including CareFirst BlueCross BlueShield, United Healthcare, Aetna, and Cigna, cover generic vardenafil on their formularies. Co-pays for generic PDE5 inhibitors typically range from $10 to $50 depending on the plan tier. Brand-name Levitra, when available, often sits on a higher formulary tier with co-pays of $50 to $75 or more.

Medicare Part D: Coverage of erectile dysfunction medications under Medicare Part D varies by plan. The Inflation Reduction Act's $2,000 annual out-of-pocket cap (effective 2025) provides some relief for Medicare beneficiaries filling vardenafil prescriptions, though plan formularies may still require step therapy through sildenafil first [8].

Labs and Screening Before Prescribing

A complete laboratory workup is not universally required before prescribing vardenafil, but most clinicians order baseline labs to rule out underlying conditions that contribute to erectile dysfunction and to ensure safe prescribing.

Commonly ordered tests include:

• Fasting glucose or HbA1c: Diabetes is present in approximately 35% to 40% of men with ED. The Massachusetts Male Aging Study found that diabetes tripled the probability of erectile dysfunction [9].
• Lipid panel: Dyslipidemia contributes to endothelial dysfunction, which is a shared pathway with ED.
• Total and free testosterone: Low testosterone is identified in roughly 20% to 25% of men presenting with ED. The Endocrine Society recommends measuring morning total testosterone in men with symptoms of hypogonadism [10].
• TSH: Thyroid dysfunction, both hyper- and hypothyroidism, can impair sexual function.
• Comprehensive metabolic panel: Assesses renal and hepatic function, which can affect vardenafil metabolism. Vardenafil dose reduction to 5 mg is recommended in patients with moderate hepatic impairment (Child-Pugh B) [3].

The cardiovascular safety screen matters. The Princeton III Consensus Guidelines classify sexual activity as moderate physical exercise (3 to 5 METs). Men at intermediate or high cardiovascular risk should undergo exercise stress testing or cardiology evaluation before starting any PDE5 inhibitor [11]. Vardenafil is absolutely contraindicated with nitrate medications due to the risk of severe hypotension.

Transferring a Prescription to Maryland

Patients who already hold a valid vardenafil prescription from another state can transfer it to a Maryland pharmacy. Maryland Board of Pharmacy regulations permit interstate prescription transfers for non-controlled substances.

The process is straightforward. Contact a Maryland pharmacy and provide the name and phone number of the out-of-state pharmacy currently holding the prescription. The receiving Maryland pharmacist will initiate a pharmacist-to-pharmacist transfer. The original pharmacy invalidates the remaining refills, and the Maryland pharmacy creates a new record.

Prescriptions can only be transferred once. If the prescription has already been transferred previously, a new prescription from a Maryland-licensed provider is required.

For telehealth patients relocating to Maryland, most platforms will assign a Maryland-licensed clinician to the patient's care team, which generates a new Maryland-originating prescription without needing a formal transfer.

E-prescriptions sent by out-of-state providers can be filled at Maryland pharmacies as long as the prescriber holds a valid license in their state and the prescription is for a non-controlled substance. Vardenafil is not a DEA-scheduled medication, so this pathway is available.

Shipping and Delivery Timelines

How quickly a Maryland resident receives vardenafil depends on the pharmacy channel selected.

Retail pharmacy pickup: If a prescriber e-prescribes to a local CVS, Walgreens, Rite Aid, or independent pharmacy, the prescription is typically ready within 2 to 4 hours. Some pharmacies may need to order generic vardenafil if it is not regularly stocked, which adds 1 business day.

Mail-order pharmacy: Large mail-order operations (Express Scripts, OptumRx, CVS Caremark) generally deliver within 3 to 5 business days via standard shipping. Expedited shipping options reduce this to 1 to 2 business days for an additional fee.

Telehealth-affiliated pharmacies: Many telehealth platforms partner with fulfillment pharmacies that ship directly to the patient. Standard delivery to Maryland addresses takes 3 to 5 business days. Some platforms offer overnight shipping.

503A compounding pharmacies: Compounded vardenafil formulations require preparation time. Expect 3 to 7 business days from prescription receipt to delivery, depending on the complexity of the formulation and the pharmacy's current queue.

Maryland does not impose any state-specific shipping restrictions on vardenafil beyond standard pharmaceutical shipping requirements (temperature control, tamper-evident packaging, valid prescription on file).

Safety, Side Effects, and Drug Interactions

The most common adverse effects reported in clinical trials of vardenafil include headache (15%), flushing (11%), rhinitis (9%), and dyspepsia (4%) [1]. These are class effects shared by all PDE5 inhibitors and are generally mild and self-limiting.

Vardenafil carries a specific warning regarding QTc prolongation. At supratherapeutic doses (80 mg, four times the maximum recommended dose), vardenafil prolonged the QTc interval by a mean of 8 milliseconds [3]. The clinical significance at standard doses (5 to 20 mg) is minimal for most patients, but prescribers avoid vardenafil in men with congenital QT prolongation or those taking Class IA (quinidine, procainamide) or Class III (amiodarol, sotalol) antiarrhythmic medications.

Absolute Contraindications:

• Concurrent nitrate use (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate)
• Concurrent guanylate cyclase stimulator use (riociguat)
• Known hypersensitivity to vardenafil

Dose Adjustments:

• Moderate hepatic impairment (Child-Pugh B): start at 5 mg, do not exceed 10 mg
• Concurrent CYP3A4 inhibitors (ketoconazole 400 mg daily, ritonavir, indinavir): do not exceed 2.5 mg per 24 hours
• Concurrent alpha-blocker therapy: stable alpha-blocker dose required; start vardenafil at 5 mg with at least 6 hours between doses [3]

A pooled analysis of 11 randomized controlled trials (N=4,400+) confirmed that vardenafil's cardiovascular safety profile was comparable to placebo, with no significant increase in myocardial infarction, stroke, or cardiovascular death [12].

Comparing PDE5 Inhibitors Available in Maryland

Maryland pharmacies stock all four FDA-approved PDE5 inhibitors. Each has distinct pharmacokinetic and clinical characteristics that influence prescriber choice.

| Feature | Vardenafil | Sildenafil | Tadalafil | Avanafil | |---|---|---|---|---| | Brand name | Levitra/Staxyn | Viagra | Cialis | Stendra | | Onset | 25-60 min | 30-60 min | 30-45 min (on-demand) | 15-30 min | | Duration | 4-5 hours | 4-6 hours | Up to 36 hours | 6-12 hours | | Food effect | High-fat meals delay absorption | High-fat meals delay absorption | Minimal food effect | Minimal food effect | | Generic available | Yes | Yes | Yes | No | | Approximate cost (generic, per tablet) | $8-25 | $1-10 | $3-15 | N/A (brand only, ~$40-70) |

The choice between agents depends on individual response, side-effect tolerance, timing preferences, and cost. In VIVID (Vardenafil in Vitro Dissolution) crossover studies, roughly 30% to 40% of men who do not respond adequately to one PDE5 inhibitor respond to a different agent in the same class [13]. Switching between medications is a recognized clinical strategy.